![rafavidalperez on Twitter: "HCM risk-SCD Calculator presented in guidelines #ESCcongress http://t.co/NsCS31snyS for sure we will need an app http://t.co/MXWpi3GWZo" / Twitter rafavidalperez on Twitter: "HCM risk-SCD Calculator presented in guidelines #ESCcongress http://t.co/NsCS31snyS for sure we will need an app http://t.co/MXWpi3GWZo" / Twitter](https://pbs.twimg.com/media/BwRgQlWIQAAGFy0.png:large)
rafavidalperez on Twitter: "HCM risk-SCD Calculator presented in guidelines #ESCcongress http://t.co/NsCS31snyS for sure we will need an app http://t.co/MXWpi3GWZo" / Twitter
![Frontiers | Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy Frontiers | Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy](https://www.frontiersin.org/files/Articles/691653/fcvm-08-691653-HTML/image_m/fcvm-08-691653-t001.jpg)
Frontiers | Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
![Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy - ScienceDirect Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1109966621001263-gr4.jpg)
Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy - ScienceDirect
![Exercise and hypertrophic cardiomyopathy: Two incompatible entities? - Basu - 2020 - Clinical Cardiology - Wiley Online Library Exercise and hypertrophic cardiomyopathy: Two incompatible entities? - Basu - 2020 - Clinical Cardiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ffeabc17-7c8b-4dc7-acae-7eed9c9a84f8/clc23343-fig-0001-m.jpg)
Exercise and hypertrophic cardiomyopathy: Two incompatible entities? - Basu - 2020 - Clinical Cardiology - Wiley Online Library
![Gaps in Evidence for Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy | Circulation Gaps in Evidence for Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy | Circulation](https://www.ahajournals.org/cms/asset/1451bf56-3f76-4ae0-a244-a4246fd005cb/circulationaha.120.051968.fig01.jpg)
Gaps in Evidence for Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy | Circulation
![2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy | Circulation 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy | Circulation](https://www.ahajournals.org/cms/asset/87f682f8-bc4d-410d-902f-5a29c2ae0017/cir.0000000000000937.utab05.gif)
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy | Circulation
![Frontiers | Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy Frontiers | Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy](https://www.frontiersin.org/files/Articles/691653/fcvm-08-691653-HTML/image_m/fcvm-08-691653-g001.jpg)
Frontiers | Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
![Discrepancy between International Guidelines on the Criteria for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Discrepancy between International Guidelines on the Criteria for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy](http://old.scielo.br/img/revistas/abc/v115n2//0066-782X-abc-115-02-0197-gf01-en.jpg)
Discrepancy between International Guidelines on the Criteria for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
![The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death | Journal of Cardiovascular Magnetic Resonance | Full The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death | Journal of Cardiovascular Magnetic Resonance | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12968-019-0561-4/MediaObjects/12968_2019_561_Fig1_HTML.png)
The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death | Journal of Cardiovascular Magnetic Resonance | Full
![145 Risk Stratification in Hypertrophic Cardiomyopathy: Evaluation of the European Society of Cardiology Sudden Cardiac Death Risk Scoring System | Heart 145 Risk Stratification in Hypertrophic Cardiomyopathy: Evaluation of the European Society of Cardiology Sudden Cardiac Death Risk Scoring System | Heart](https://heart.bmj.com/content/heartjnl/102/Suppl_6/A104.2/F1.large.jpg)